Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre.

Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; EOC Competence Centre for Thyroid Diseases, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. Electronic address: luca.giovanella@eoc.ch. Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; EOC Competence Centre for Thyroid Diseases, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

Best practice & research. Clinical endocrinology & metabolism. 2014;(4):507-18
Full text from:

Abstract

Nuclear medicine techniques were first used in clinical practice for diagnosing and treating thyroid diseases in the 1950s, and are still an integral part of thyroid nodules work-up. Thyroid imaging with iodine or iodine-analogue isotopes is the only examination able to prove the presence of autonomously functioning thyroid tissue, which excludes malignancy with a high probability. In addition, a thyroid scan with technetium-99m-methoxyisobutylisonitrile is able to avoid unnecessary surgical procedures for cytologically inconclusive thyroid nodules, as confirmed by meta-analysis and cost-effectiveness studies. Finally, positron emission tomography alone, and positron emission tomography combined with computed tomography scans with (18)F-fluoro-2-deoxy-d-glucose are also promising for diagnosing thyroid diseases, but further studies are needed before introducing them to clinical practice.

Methodological quality

Publication Type : Review

Metadata